Stryker recently announced that it has completed the acquisition of Amplitude Vascular Systems (AVS), developer of a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease (PAD).
“This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, chair and CEO, Stryker. “By integrating AVS’s innovative CO₂-generated pressure wave technology with Stryker’s scale and resources, we are well-positioned to deliver solutions that support physicians and patient outcomes.”
The addition of an IVL platform will strengthen Stryker’s impact in peripheral vascular solutions, the company states in a press release.
